Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 18597551.
- Also identified by DOI 10.1371/journal.pmed.0050145 and PMC identifier 2443198.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Willem Hanekom and colleagues make recommendations on assay harmonization for novel tuberculosis vaccine trials.
Medical subject headings
- Clinical Trials as Topic
- Health Planning Guidelines
- Tuberculosis Vaccines
- World Health Organization